Uropartners

Glenview, Illinois 60026

2 studies enrolling now · 3 studies all time

What they study most

High-Risk Non-Muscle-Invasive Bladder Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Prostate Cancer

Studies at this site

• Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now
• Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T — Recruiting now
• SpaceIT Hydrogel System for Perirectal Spacing — Running, not enrolling